lithospermate b has been researched along with Diabetic Angiopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, DS; Cho, JW; Choi, M; Jung, M; Kang, ES; Kim, SH; Kim, YH; Kim, YO; Lee, EJ; Lee, HC; Lee, Y; Williams, DR | 1 |
1 other study(ies) available for lithospermate b and Diabetic Angiopathies
| Article | Year |
|---|---|
Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction.
Topics: Animals; Antioxidants; Apoptosis; Cell Adhesion; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Drugs, Chinese Herbal; Endothelium, Vascular; Glucose; Glycation End Products, Advanced; Glycosylation; Heme Oxygenase-1; Humans; Leukocytes; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Reactive Oxygen Species; Time Factors; Vasodilation | 2010 |